Platinum-based chemotherapy is a gold standard of first-line treatment for metastatic GC with negative human epidermal growth factor receptor 2 (Her2-neu) expression and microsatellite stable subtype (MSS) (4–7). This evidence concerns the gene ERBB2 and gastric cancer.